Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience

por Nanaa, Ahmad, Viswanatha, David, Xie, Zhuoer, Jevremovic, Dragan, Nguyen, Phuong, Salama, Mohamad E., Greipp, Patricia, Bessonen, Kurt, Gangat, Naseema, Patnaik, Mrinal, Pardanani, Animesh, Alkhateeb, Hassan B., Shah, Mithun, Hogan, William, Tefferi, Ayalew, Litzow, Mark, He, Rong, Al-Kali, Aref
Publicado 2021

Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience

por Katamesh, Bahga, Nanaa, Ahmad, He, Rong, Viswanatha, David, Nguyen, Phuong, Greipp, Patricia, Bessonen, Kurt, Gangat, Naseema, Begna, Kebede, Mangaonkar, Abhishek, Patnaik, Mrinal, Hogan, William J., Tefferi, Ayalew, Litzow, Mark, Shah, Mithun Vinod, Yi, Cecilia Arana, Foran, James, Badar, Talha, Alkhateeb, Hassan B., Al-Kali, Aref
Publicado 2022

Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations

por Venable, Elise R, Chen, Dong, Chen, Constance P, Bessonen, Kurt R, Nguyen, Phuong L, Oliveira, Jennifer L, Reichard, Kaaren K, Hoyer, James D, Althoff, Simon D, Roh, Dana J, Miller, Mechelle A, Begna, Kebede, Patnaik, Mrinal M, Litzow, Mark R, Al-Kali, Aref, Viswanatha, David S, He, Rong
Publicado 2021

Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

por He, Rong, Chiou, Jonathan, Chiou, Allison, Chen, Dong, Chen, Constance P., Spethman, Caroline, Bessonen, Kurt R., Oliveira, Jennifer L., Nguyen, Phuong L., Reichard, Kaaren K., Hoyer, James D., Althoff, Simon D., Roh, Dana J., Miller, Mechelle A., Yuan, Ji, Olteanu, Horatiu, Begna, Kebede, Tefferi, Ayalew, Alkhateeb, Hassan, Patnaik, Mrinal M., Litzow, Mark R., Al-Kali, Aref, Viswanatha, David S.
Publicado 2022